Skip to main content
. 2022 Jul 19;14(14):3495. doi: 10.3390/cancers14143495

Figure 3.

Figure 3

Association of HSPG2 mutations with mutational burden in melanoma. (A) Distinct TMB distribution in HSPG2-mutated versus wild-type subgroups. (B) Multivariate logistic regression model of HSPG2 mutations was performed with clinical and genomic confounders taken into consideration. (C) Distinct NB distribution in HSPG2-mutated versus wild-type subgroups. Connection of HSPG2 mutations with (D) TMB and (E) NB based on the data from the TCGA melanoma cohort.